US2017204122A1PendingUtilityA1
Methods for the synthesis of sphingomyelins and dihydrosphingomyelins
Assignee: CERENIS THERAPEUTICS HOLDING SAPriority: Mar 15, 2013Filed: Apr 4, 2017Published: Jul 20, 2017
Est. expiryMar 15, 2033(~6.7 yrs left)· nominal 20-yr term from priority
C07F 9/10C07F 9/141Y02P20/55C07C 249/02C07C 231/12C07C 231/02C07B 2200/07C07C 215/24C07C 231/10C07C 233/18C07F 9/113C07C 213/08
54
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention includes methods for the synthesis of sphingomyelins and dihydrosphingomyelins. The present invention also includes methods for the synthesis of sphingosines and dihydrosphingosines. The present invention further includes methods for the synthesis of ceramides and dihydroceramides.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A method for synthesizing N-palmitoyl-D-erythro-dihydrosphingomyelin, comprising the steps of:
a) allowing N-palmitoyl-D-erythro-dihydrosphingosine to react with ethylene halophosphite under conditions effective to yield N-((2S,3R)-1-((1,3,2-dioxaphospholan-2-yl)oxy)-3-hydroxyoctadecan-2-yl)palmitamide; b) allowing N-((2S,3R)-1-((1,3,2-dioxaphospholan-2-yl)oxy)-3-hydroxyoctadecan-2-yl)palmitamide to react with bromine under conditions effective to yield 2-bromoethyl ((2S,3R)-3-hydroxy-2-palmitamidooctadecyl) phosphorobromidate; and c) allowing 2-bromoethyl ((2S,3R)-3-hydroxy-2-palmitamidooctadecyl) phosphorobromidate to react with trimethylamine under conditions effective to yield N-palmitoyl-D-erythro-dihydrosphingomyelin.
2 . The method of claim 1 wherein the ethylene halophosphite is ethylene chlorophosphite.
3 . A method for synthesizing N-palmitoyl-3-O-benzoyl-D-erythro-dihydrosphingomyelin, comprising the steps of:
a) allowing N-palmitoyl-3-O-benzoyl-D-erythro-dihydrosphingosine to react with 2-chloro-2-oxo-1,3,2-dioxaphospholane (CCP) under conditions effective to yield N-palmitoyl-3-O-benzoyl-D-erythro-1-O-(2-oxo-1,3,2-dioxaphospholane)-dihydrosphingosine; and b) allowing N-palmitoyl-3-O-benzoyl-D-erythro-1-O-(2-oxo-1,3,2-dioxaphospholane)-dihydrosphingosine to react with trimethylamine under conditions effective to yield N-palmitoyl-3-O-benzoyl-D-erythro-dihydrosphingomyelin.
4 . The method of claim 3 , wherein N-palmitoyl-3-O-benzoyl-D-erythro-1-O-(2-oxo-1,3,2-dioxaphospholane)-dihydrosphingosine is not purified or isolated.
5 . A method for synthesizing N-palmitoyl-D-erythro-dihydrosphingomyelin, comprising performing the method of claim 3 and allowing N-palmitoyl-3-O-benzoyl-D-erythro-dihydrosphingomyelin to react with sodium methoxide under conditions that are effective to yield N-palmitoyl-D-erythro-dihydrosphingomyelin.
6 . The method of claim 3 , wherein the trimethylamine is added as a liquid.
7 . The method of claim 3 , wherein the trimethylamine is added in a gaseous form.
8 . The method of claim 3 , wherein the method is performed on a kilogram scale.
9 . The method of claim 3 , wherein N-palmitoyl-3-O-benzoyl-D-erythro-ceramide is allowed to react with 2-chloro-2-oxo-1,3,2-dioxaphospholane in the presence of tetramethylethylenediamine.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.